market access

News

NICE backs NHS funding for two cannabis-based drugs for firs...

NICE has recommended two of GW Pharma's cannabis-based medicines, the first time that medicines derived from the plant have been recommended for NHS funding.

News

Open Health merges with HEOR and market access firm Pharmeri...

Open Health has joined forces with health economics and outcomes research (HEOR) company Pharmerit International in a move that strengthens its existing market access capabilities.

News

FDA finally approves Sandoz's Neulasta biosimilar, but will ...

The FDA has approved Sandoz’s pegfilgrastim biosimilar, a cheaper version of Amgen’s long-lasting and big-selling white blood cell booster Neulasta.

News

After four-year wait, patients in England finally get Vertex...

NHS England has signed an agreement with US pharma Vertex covering all the company’s licensed cystic fibrosis medicines, and any future uses for them.

News

MSF calls for J&J to cut price of TB medicine

The humanitarian medical organisation Medecins Sans Frontieres (MSF) has called on Johnson & Johnson to cut the price of its anti-tuberculosis medicine Sirturo (bedaquiline), to not mor

News

Lack of reimbursement an issue for digital health products, ...

Many healthcare companies still don’t see digital health companies as viable partners despite recent progress in the industry, according to a new survey.

NICE backs NHS funding for two cannabis-based drugs for firs...

Open Health merges with HEOR and market access firm Pharmeri...

FDA finally approves Sandoz's Neulasta biosimilar, but will ...

After four-year wait, patients in England finally get Vertex...

MSF calls for J&J to cut price of TB medicine

Lack of reimbursement an issue for digital health products, ...

Nuvalent buy delivers new cancer approval for GSK

Discover a new era of healthcare panel engagement: Grounded ...

market access

Editor's Picks